e-learning
resources
Monograph
2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The use of pre-conditioning and novel assays in the development of protocols for transplantation of lung progenitors
Chava Rosen, Yair Reisner
Source:
Eur Respir Monogr 2021; 91: 232-247
Journal Issue:
Lung Stem Cells in Development, Health and Disease
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Chava Rosen, Yair Reisner. The use of pre-conditioning and novel assays in the development of protocols for transplantation of lung progenitors. Eur Respir Monogr 2021; 91: 232-247
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Successful transplantation of rat mesenchymal stem cells, for the therapy of bleomycin induced lung injury
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Early lung function alterations after allogeneic hematopoietic stem cell transplantation
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010
Towards human lung regeneration in end-stage respiratory failure: genetically-modifiable 3D organoid culture of human embryonic lung stem cells enables for the first time the study of human lung development in vitro
Source: ERS Lung Science Conference 2018
Year: 2018
Restrictive chronic lung function decline after haematopoietic stem cell transplantation
Source: Eur Respir J 2016; 47: 336-339
Year: 2016
Progress towards human lung regeneration in end-stage respiratory failure: studying human lung development in vitro using organoid cultures of human embryonic lung stem cells
Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration
Year: 2018
iPSC derived lung stem cells as tools to understand lung regeneration and disease
Source: ERS Lung Science Conference 2021
Year: 2021
Detection of late post stem cell transplantation lung function deterioration using simple spirometry.
Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Year: 2018
Relationship among physical activity, pulmonary functions and physical functions in candidates of allogeneic hematopoietic stem cell transplantation.
Source: Virtual Congress 2020 – Physical activity and chronic lung disease
Year: 2020
Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD.
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020
The new-defined mesenchymal stromal/stem cell marker has a protective role in the development of acute lung injury.
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019
Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Source: Eur Respir J 2009; 34: 740
Year: 2009
NKG2D mediated cytotoxicity towards respiratory epithelial cells suggests a mechanism for lung injury following allogeneic stem cell transplantation
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007
3D models of human lung development and disease using pluripotent stem cells
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019
Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011
Pretransplant lung function tests in patients with malignant hemopathy undergoing stem cell transplantation.
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021
Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Late Breaking Abstract - Enhancing the antimicrobial efficacy of mesenchymal stem cells (MSCs) to combat sepsis-induced acute lung injury (ALI) using a novel combination of immune-stimulants
Source: International Congress 2017 – Late-breaking findings in pulmonary diseases
Year: 2017
In search of ckit+ stem cells in lung tissue
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept